Liver Bioservices

Barcelona Liver Bioservices. CRO specialized in Hepatology, we work with our partners to accelerate the development of new drug entities to beat liver disease

[Liver Bioservices @LiverBio]

🎄✨ Merry Christmas and a Happy New Year! ✨🎄

Warm wishes from all of us at Barcelona Liver Bioservices.

Thank you for being part of our journey— here’s to a healthy, successful, and innovative year ahead! 🌟

[Liver Bioservices @LiverBio]

🎉 Celebrating 8 years of innovation at Barcelona Liver Bioservices!

Together with our partners, we’re accelerating drug development to fight liver diseases. 💚🧬

Excited to keep expanding our innovative portfolio and launching new projects at the boundaries of liver research!

[Pharmacology Valencia @pharmacologyvlc]

The Best Communication Award at the 3rd International Workshop on Liver and Gut Fibrosis goes to @Maria_andresdr from @LiverBio for her presentation on a microfluidic human liver slice model for drug screening (see description) Congrats to María & thanks to sponsor @Biomol_MDPI

[Liver Bioservices @LiverBio]

📢 New study from BLB❗️

Sex-specific differences in liver disease models show males with more fibrosis & inflammation, females with distinct endothelial & fibrotic traits.

Part of our R&D, committed to 3Rs & translational research.

Free read 🔗 https://t.co/6FvpHG6FYq

[Liver Bioservices @LiverBio]

Season Greetings from Barcelona Liver Bioservices! 🎄💫

We’re grateful for all the collaborations in advancing #liver disease #research. Here’s to a successful 2025 filled with new diacoveries and impactful partnerships! 🥂

#HappyHolidays

[Liver Bioservices @LiverBio]

Warmest holiday greetings to the entire scientific community from BLB! May this festive season bring you joy, inspiration, and breakthrough discoveries. Wishing you a Merry Christmas and a prosperous New Year filled with scientific achievements!🔬#MerryChristmas #HappyNewYear2024

[Liver Bioservices @LiverBio]

Our Team Matters Beyond Biomedical Research

➡️ https://t.co/50DP3c9SOz

[Liver Bioservices @LiverBio]

#LiverTwitter #hepatology #liverdiseases #sinusoid #aCDL #innovation #preclinicalmodels #clinicalresearch #3Dmodels #livercells #biomedicine #biotechnology #pharma #development #NASH #Cirrhosis #NAFLD #partnership

[Liver Bioservices @LiverBio]

Have you ever thought about the importance of hepatic microcirculation in liver diseases?

Understanding the mechanisms involved in hepatic microvascular is crucial for diagnosing and managing liver disorders

📢Check out our latest publication on Linkedin
https://t.co/5Mf6maXCjM

[Liver Bioservices @LiverBio]

Happy holidays from the entire BLB’s team!
This holiday season we celebrate 5 years developing preclinical research in Hepatology 💫

[Liver Bioservices @LiverBio]

Latest BLB research published in the Journal of Hepatology:

https://t.co/4UiJ5hS6nh

[Jordi Gracia-Sancho @JSGracia]

Fresh from the oven!

Very happy to share with you our latest collaborative work, just published in @JHepatology:

📖 Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental #cirrhosis

Open access ➡️ https://t.co/R6tgMabtjf

#livertwitter

[jaumebosch @jaumebosch9]

#livertwitter
📌 Lanifibranor shown to be effective in NASH in a phase2b RCT of 24 week Rx
✳️ Meets all primary end-points for NASH of both FDA and EMA & reduces fibrosis
✳️ Data in a press release by Inventiva
✳️ The RCT confirms our study in cirrhotic rats at last AASLD

[CaixaResearch @CaixaResearchCA]

A major hurdle in drug development is correctly identifying candidates with low liver toxicity.💊

The "Liver on a Chip" platform by @idibaps spin-off and #CaixaImpulse project ExoLiver mimics the liver environment, allowing proper toxicology testing.

👇
https://t.co/h4bjPwfYZE

[Liver Bioservices @LiverBio]

Season’s Greetings from the Barcelona Liver Bioservices Team!

[Liver Bioservices @LiverBio]

Today at the #LiverMtg19 Zoe Boyer-Diaz, senior associate scientist, presents the work “hepatic fatty acid profile in chronic #liver #disease: mechanism of injury and novel therapeutic target”. Come by to the posters area and learn about this and other projects of BLB!

[Javier Cubero @CUBEROlab]

Great Early Morning Workshop together with Prof. Natalie Török @StanfordUniver the Liver Meeting 2019 #Boston @AASLDtweets and excellent presentations from Dr. Pedro Rodrigues @PMRodrigues19 @Biodonostia and Peio Aristu @LiverBio @unicomplutense

[Liver Bioservices @LiverBio]

Dr Gracia-Sancho @jsgracia, presents the effects and underlying mechanisms of 2-week lanifibranor on portal hypertension, hepatic microcirculatory dysfunction and liver fibrosis in pre-clinical advanced cirrhosis. #NASH #LiverMtg19

[Liver Bioservices @LiverBio]

Glad to announce our participation in the upcoming #LiverMtg19 in #Boston!! Our team looks forward to sharing our science and meeting current & new partners! Click to know more 👉🏼 https://t.co/dDvWEG9ri8

[Liver Bioservices @LiverBio]

Happy to announce the publication of the manuscript “A nutraceutical rich in DHA improves portal hypertension in #cirrhosis” in the journal @Nutrients_MDPI. Fruit of our collaboration with BrudyLab. Read here the press release: https://t.co/w4Dg3nwjCz #liver